Moreover, the sensitivity to this inhibitor correlates with the degree of CIN, suggesting that cancers with elevated CIN may benefit from CENP-E-targeted therapy [423]. The gene discussed is CENPE; the disease is cervical squamous intraepithelial neoplasia.